Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada

被引：0
|
作者：
Stephanie R Earnshaw
Cheryl L McDade
Giovanni Zanotti
Raymond A Farkouh
David Strutton
机构：
[1] RTI Health Solutions,
[2] Pfizer Canada Inc.,undefined
[3] Pfizer Inc.,undefined
来源：
BMC Infectious Diseases | / 12卷
关键词：
Vaccine; Cost-effectiveness; Pneumococcal conjugate vaccine; Pneumococcal disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Cost-effectiveness of 2+1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
    Earnshaw, Stephanie R.
    McDade, Cheryl L.
    Zanotti, Giovanni
    Farkouh, Raymond A.
    Strutton, David
    [J]. BMC INFECTIOUS DISEASES, 2012, 12
  • [2] COST-EFFECTIVENESS OF 13-VALENT AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION RELATIVE TO 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN CANADA
    Whillans, F.
    Kwan, H.
    Strutton, D. R.
    Earnshaw, S. R.
    Farkouh, R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A425 - A425
  • [3] A COMPARISON OF THE COST-EFFECTIVENESS OF THE 13-VALENT (PCV13) AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINES IN THE UK
    Patel, R.
    Stoykova, B.
    Lloyd, A. C.
    Willingham, J.
    Hollingsworth, R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A428 - A428
  • [4] COST-EFFECTIVENESS OF 2+1 DOSING OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE COMPARED WITH 2+1 DOSING OF 10-VALENT CONJUGATE VACCINE IN PREVENTING PNEUMOCOCCAL DISEASE IN CANADA
    Earnshaw, S.
    McDade, C.
    Zanotti, G.
    Farkouh, R. A.
    Strutton, D.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A275 - A275
  • [5] Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: Comparing estimates for 7-valent, 10-valent, and 13-valent vaccines
    Tyo, Karen Richards
    Rosen, Melissa M.
    Zeng, Wu
    Yap, Mabel
    Pwee, Keng Ho
    Ang, Li Wei
    Shepard, Donald S.
    [J]. VACCINE, 2011, 29 (38) : 6686 - 6694
  • [6] COST-EFFECTIVENESS OF SWITCHING FROM THE 10-VALENT TO THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN SWEDEN
    Wasserman, M.
    Dorange, A. C.
    Palmborg, A.
    McDade, C.
    Wilson, M.
    Horn, E.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S110 - S110
  • [7] Pneumococcal immunization with conjugate vaccines: are 10-valent and 13-valent vaccines similar?
    Esposito, Susanna
    Principi, Nicola
    [J]. FUTURE MICROBIOLOGY, 2019, 14 (11) : 921 - 923
  • [8] Pneumococcal immunization with conjugate vaccines - are 10-valent and 13-valent vaccines similar?
    Vyse, Andrew
    Theilacker, Christian
    Sings, Heather
    Fletcher, Mark
    [J]. FUTURE MICROBIOLOGY, 2020, 15 (08) : 575 - 578
  • [9] Assessment of Health Benefits and Cost-Effectiveness of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Kenyan Children
    Ayieko, Philip
    Griffiths, Ulla K.
    Ndiritu, Moses
    Moisi, Jennifer
    Mugoya, Isaac K.
    Kamau, Tatu
    English, Mike
    Scott, J. Anthony G.
    [J]. PLOS ONE, 2013, 8 (06):
  • [10] Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease
    Theilacker, Christian
    Hilton, Betsy
    Jiang, Qin
    Gessner, Bradford D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (10) : 1641 - 1642
12345